Australia markets closed

AC Immune SA (ACIU)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.3700-0.0100 (-0.42%)
At close: 04:00PM EDT
2.3300 -0.04 (-1.69%)
After hours: 04:28PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,934
14,801
3,935
0
15,431
Operating expenses
Research development
65,324
54,606
60,336
62,282
59,487
Selling general and administrative
7,714
10,576
9,582
10,879
11,086
Total operating expenses
78,871
68,425
74,782
79,010
76,691
Operating income or loss
-74,937
-53,624
-70,847
-79,010
-61,260
Interest expense
529
176
355
581
184
Total other income/expenses net
128
-1,467
393
113
-555
Income before tax
-73,266
-54,223
-70,740
-72,993
-61,921
Income tax expense
14
10
13
3
0
Income from continuing operations
-73,280
-54,233
-70,753
-72,996
-61,921
Net income
-73,280
-54,233
-70,753
-72,996
-61,921
Net income available to common shareholders
-73,280
-54,233
-70,753
-72,996
-61,921
Basic EPS
-0.82
-0.64
-0.85
-0.97
-0.86
Diluted EPS
-0.82
-0.64
-0.85
-0.97
-0.86
Basic average shares
83,910
84,695
83,554
74,952
71,900
Diluted average shares
83,910
84,695
83,554
74,952
71,900